Steve Nissen, MD: Optimizing Lp(a) Management by Learning from Missteps with LDL-C
Steve Nissen, MD, discusses how the cardiology community needs to learn from previous mistakes in uptake of LDL-C lowering therapies as it approaches an age of Lp(a)-lowering agents.
Family Heart Foundation Launches Cholesterol Connect: Free At-Home Lipid Screening
Family Heart Foundation announces the launch of Cholesterol Connect, a program that provides free at-home lipid screening and personalized support.
Christie Ballantyne, MD: 'Exciting' Time for FCS Pipeline
A comparison of the PALISADE and BALANCE trials, with commentary from a leading cardiologist, as the community nears a potential approval in FCS.
Fatima Rodriguez, MD, MPH: AI in the Clinical Cardiology Space
HCPLive spoke to Rodriguez, MD, MPH, about implementing AI in cardiology care.
Harpreet Bhatia, MD: Benefits of Universal Screening for Lp(a) Levels
At the Family Heart Global Summit 2024, Bhatia spoke about the importance of universal Lp(a) screening over only targeted screening.
Promising Emergent Therapies for Lowering Lp(a), with Michelle O’Donoghue, MD, MPH
In an interview O’Donoghue talked about emerging RNA therapies for Lp(a) in phase 2 and 3 trials.
Advances in Non-Statin Therapies for Dyslipidemia, with Christie Ballantyne, MD
Christie Ballantyne, MD, discusses non-statin therapies, both approved and in development, for managing dyslipidemias from the floor of the 2024 Family Heart Global Summit.
Using Technology to Advance Care in Hyperlipidemia, Cardiovascular Disease, with Nihar Desai, MD
A Q&A with Nihar Desai, MD, on the PROMPT-Lipid trial and the potential of advancing technology for improving patient care in pragmatic ways.
The Value of Team-Based Care, Technology in Managing CVD Risk Factors, with Benjamin Scirica, MD
Benjamin Scirica, MD, discusses the importance of team-based care and leveraging technology to optimize the management of cardiovascular risk factors.
Heather Johnson, MD: How to Combat Misconceptions of Statin Drugs in Your Patients
HCPLive spoke to Johnson on how strategies for addressing patient misconceptions about cholesterol management.
Nihar Desai, MD: PROMPT-Lipid and EHR-Based Interventions for Improving Care
Nihar Desai, MD, discusses the results of the PROMPT-Lipid trial while on-site at the 2024 Family Heart Global Summit.
Laurence Sperling, MD: Population Health Approaches to Cardiovascular Disease Prevention
Laurence Sperling, MD, discusses his presentation from the 2024 Family Heart Global Summit examining public health efforts for prevention of cardiovascular disease.
PROMPT-Lipid Trial Shows EMR Tools Improve LDL Cholesterol Management
At the Family Heart Summit, Nihar Desai, MD, discussed using EMR alerts to improve lipid therapy for high-risk ASCVD, as shown in the PROMPT-Lipid trial.
New Analysis from Family Heart Database Shows LDL-C Management Trends
The analysis of LDL-C Management Trends observed disparities in LDL-C goal attainment by race, gender, and age.
Laurence Sperling, MD: Navigating the Changing Landscape of Lipidology
Laurence Sperling, MD, offers perspective on multiple topics within the evolving field of lipid management and dyslipidemia.
Previewing the Family Heart Global Summit, with Laurence Sperling, MD
Laurence Sperling, MD, provides an overview of the Family Heart Global Summit, including previewing the meeting and discussing where interested attendees can learn more.
